Karel Helman
5PUBLICATIONS
19CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 11, 2026
The impact of health risks on healthcare expenditure in European countries.Jarmila Zimmermannová, Karel Helman, Miroslav Hájek
|May 07, 2024
Blockage of BCL-XL overcomes venetoclax resistance across BCL2+ lymphoid malignancies irrespective of BIM status.Alexandra Dolnikova, Dmitry Kazantsev, Magdalena Klanova
|Nov 03, 2021
Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas.Magdalena Klanova, Dmitry Kazantsev, Eva Pokorna
|Dec 14, 2019
Preclinical Evaluation of a Novel SHIP1 Phosphatase Activator for Inhibition of PI3K Signaling in Malignant B Cells.Elizabeth A Lemm, Beatriz Valle-Argos, Lindsay D Smith
|Apr 21, 2019
Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal <i>In Vivo</i> in Relapsed Mantle Cell Lymphoma.Dana Prukova, Ladislav Andera, Zuzana Nahacka
Pageof 1
Frequent Collaborators
4 joint publications
Pavel Klener
3 joint publications
Jana Karolova
1 joint publications
Petra Vockova
1 joint publications
Eva Fronkova
1 joint publications
Johanna Richter
1 joint publications
Nicola J Weston-Bell
1 joint publications
Mark Cragg
1 joint publications
Francesco Forconi
1 joint publications
Andrew J Steele
1 joint publications
Tomas Zikmund
